To link to the entire object, paste this link in email, IM or documentTo embed the entire object, paste this HTML in websiteTo link to this page, paste this link in email, IM or documentTo embed this page, paste this HTML in website

Implementation of risk management in medical device companies: a survey analysis of current practices

IMPLEMENTATION OF RISK MANAGEMENT IN
MEDICAL DEVICE COMPANIES:
A SURVEY ANALYSIS OF CURRENT PRACTICES
by
Tony C. Chan
__________________________________________________________________
A Dissertation Presented to the
FACULTY OF THE USC SCHOOL OF PHARMACY
UNIVERSITY OF SOUTHERN CALIFORNIA
In Partial Fulfillment of the
Requirements for the Degree
DOCTOR OF REGULATORY SCIENCE
December 2012
Copyright 2012 Tony C. Chan

This survey analysis examined current practices related to the implementation of risk management in medical device companies. Twenty-six of the Top 30 (by global market revenues) and twenty-seven other medical device companies with direct product sales in the U.S. market participated in the study. Through a literature analysis, the researcher developed a systematic framework, the “Behavior+Capability” model, to explore risk management attitudes and practices of a medical device company according to six dimensions. This framework was used to construct a forty-question survey instrument for the study. Most respondents to the survey classified their companies as relatively risk averse. Most viewed their risk management systems as satisfactory but some elements, such as risk communication, independence of risk managers, breadth of risk tools and methods to capture lessons learned, were not well-developed. Respondents in most companies and particularly the largest companies judged their risk management systems as relatively immune to the current economic climate. Most systems appeared to be highly driven by regulatory requirements rather than business imperatives. ❧ Results suggested that initiatives to achieve best practices in risk management might be improved by incorporating more advanced approaches and applications of risk management tools and techniques. More research on specific aspects of weakness identified for some companies might elucidate root causes for the challenges. Risk management systems might be enhanced further in medical device companies by expansion of training for typical in-house activities to include outside certification or graduate programs, or by introducing risk management as part of curricula in engineering or regulatory science programs.

The author retains rights to his/her dissertation, thesis or other graduate work according to U.S. copyright law. Electronic access is being provided by the USC Libraries in agreement with the author, as the original true and official version of the work, but does not grant the reader permission to use the work if the desired use is covered by copyright. It is the author, as rights holder, who must provide use permission if such use is covered by copyright. The original signature page accompanying the original submission of the work to the USC Libraries is retained by the USC Libraries and a copy of it may be obtained by authorized requesters contacting the repository e-mail address given.

IMPLEMENTATION OF RISK MANAGEMENT IN
MEDICAL DEVICE COMPANIES:
A SURVEY ANALYSIS OF CURRENT PRACTICES
by
Tony C. Chan
__________________________________________________________________
A Dissertation Presented to the
FACULTY OF THE USC SCHOOL OF PHARMACY
UNIVERSITY OF SOUTHERN CALIFORNIA
In Partial Fulfillment of the
Requirements for the Degree
DOCTOR OF REGULATORY SCIENCE
December 2012
Copyright 2012 Tony C. Chan